NWS
69
5
EBAY
42
2
NOV
45
2
HBI
53
4
V
70
14
GOOG
77
14
DD
44
2
MDLZ
28
2
XOM
33
3
SYF
78
7
THC
52
9
PVH
58
5
INTC
35
4
SBUX
29
-2
CAH
44
7
PSA
43
6
PEP
33
4
ABBV
40
5
HRB
40
3
AN
49
2
NWS
69
5
EBAY
42
2
NOV
45
2
HBI
53
4
V
70
14
GOOG
77
14
DD
44
2
MDLZ
28
2
XOM
33
3
SYF
78
7
THC
52
9
PVH
58
5
INTC
35
4
SBUX
29
-2
CAH
44
7
PSA
43
6
PEP
33
4
ABBV
40
5
HRB
40
3
AN
49
2
Financhill
Back

Sage Therapeutics Stock Predictions

The AI Energy Miracle

Details Here.
Sell
34

SAGE
Sage Therapeutics

Last Price:
$5.61
Seasonality Move:
0.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 3.7% based on the past 10 years of stock performance.
  • Sage Therapeutics has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $5.61. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 3.7% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
34
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has risen higher in 3 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • The current trend is relatively stagnant and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
28.26
52-Week Low:
4.62

Prediction Charts

Market Cap:
343.2M
Price in USD:
5.61
Volume:
4.3M
Beta:
1.32

Technical Analysis

SMA50:
6.08
SMA100:
6.97
SMA200:
10.31
52-Wk Change:
-73.13%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 5.61 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 5.78 5.60 5.78 5.53
Dec-4 5.67 5.61 5.79 5.58
Dec-5 5.52 5.60 5.82 5.52
Dec-6 5.60 5.61 5.81 5.50
Dec-9 5.68 5.56 5.80 5.54
Dec-10 5.50 5.57 5.69 5.42
Dec-11 5.61 5.89 5.91 5.51
Dec-12 5.73 5.67 5.76 5.54
Dec-13 5.66 5.39 5.72 5.03
Dec-16 5.32 5.35 5.54 5.17
Dec-17 5.29 5.27 5.48 5.07
Dec-18 5.32 5.03 5.38 4.94
Dec-19 5.11 5.00 5.16 4.96
Dec-20 5.06 5.61 5.62 4.95

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.77 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.